OncoSil Medical LtdASX: OSL

Australian institution to invest $2.7 million in OSL

· Issued by OncoSil Medical Ltd

Filed with ASX · · 2 pages · English

Summary by 6ix AI

OncoSil Medical Ltd has announced a commitment for an investment from an Australian institutional investor to raise funds through a placement. The placement will generate significant capital to support the commercialization and regulatory accreditation of the OncoSil device for pancreatic cancer treatment. The investment will also aid in manufacturing optimization and fund clinical trials to expand the device's approval. Following the placement, the institutional investor will hold a notable percentage of the company's issued shares.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases